Chronic rhinosinusitis and omalizumab: eosinophils not IgE predict treatment response in real-life
Background: Chronic rhinosinusitis with and without nasal polyps (CRSwNP and CRSsNP respectively) can be difficult to treat and biologics offer potential as a future therapeutic intervention. CRS and severe asthma often co-exist. Omalizumab is currently licenced for the treatment of severe allergic...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Stichting NASE
2018-10-01
|
| Series: | Rhinology Online |
| Subjects: | |
| Online Access: | https://www.rhinologyonline.org/Rhinology_online_issues/manuscript_33.pdf |